about
Aspirin for preventing the recurrence of venous thromboembolism.Challenges in the diagnosis and treatment of neurosarcoidosis.Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.Purplish arm with bullous lesions.Extended oral anticoagulant therapy after a first episode of pulmonary embolism.A randomized trial comparing 1 mg of oral vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves.New trends in ultrasound of hepatosplenic sarcoidosis.Emphysematous pancreatitis associated with penetrating duodenal ulcer.Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort study.Italian intersociety consensus on DOAC use in internal medicine.Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study.Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study.Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.The secondary prevention of venous thromboembolism: Towards an individual therapeutic strategyLong-term outcomes of patients with cerebral vein thrombosis: a multicenter studyAcute myocardial necrosis associated with spontaneous right pneumothoraxHelicobacter pylori, a frequent and potentially dangerous guest in the gastroduodenal mucosa of anticoagulated patientsIncidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulationThe incidence of venous thromboembolism following gynecologic laparoscopy: a multicenter, prospective cohort studyIncidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolismA prospective study on cardiovascular events after acute pulmonary embolismIncidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study
P50
Q34276812-8C4BB745-A79E-4A91-B799-80F876221387Q38607759-D6450873-573E-48FD-A6DC-A3C221B9D73DQ40977419-D03B053C-C780-4B81-9DE2-DB0C58EAB2C1Q42101622-10A4583E-622F-420E-B523-E598E1BC945AQ44496670-3D714C2C-4E6C-487A-BF47-E861651E20D6Q46648632-BB089704-D770-4233-A6EA-C0F7547C7B48Q48522285-CD4EF0DD-8811-44CA-B57B-A6039CE26E18Q49188252-01294582-7C07-4442-9570-3625661AB473Q50112669-1DFA48E5-C4EA-4A18-8EBF-C3E2A7054BC2Q50896785-6DBEDF45-962B-43B8-B197-2485A5C893BBQ51374855-CD81CE6A-B2A0-4302-A9C5-F9F269320732Q51423235-C21E6CEC-B9AC-4BD0-8D0B-EF9319CDEC55Q53850167-72B01C00-0E2B-4D3B-AC1A-0DBD97B19E9EQ56927678-B9D1BCED-F9C1-4C09-B6C8-CB2094951595Q57969761-6BB3438F-DF15-417B-8C2B-DBAECEAAC5C1Q72565604-0AC6552F-6D1D-4FA9-B472-934F6CE41CE6Q73318637-2A6E823B-A54E-46D9-8EA7-5B87E76EB414Q73794520-A3588A76-8E14-4D09-87F8-2EB00C84073EQ79339533-D322D8B1-6267-4501-8D17-C24B3EA676EDQ79902645-7CCD149F-0362-4231-9F7C-B7625503B060Q81190773-E3953E73-53F9-4263-A77F-F96C4C60EEB1Q84602101-37F923C6-0EEF-4689-952A-14C7CDA22191
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mauro Silingardi
@ast
Mauro Silingardi
@en
Mauro Silingardi
@es
Mauro Silingardi
@nl
type
label
Mauro Silingardi
@ast
Mauro Silingardi
@en
Mauro Silingardi
@es
Mauro Silingardi
@nl
prefLabel
Mauro Silingardi
@ast
Mauro Silingardi
@en
Mauro Silingardi
@es
Mauro Silingardi
@nl
P106
P1153
6603450083
P31
P496
0000-0002-9518-8725